Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
SpyGlass Pharma Stock Jumps in First Day of Trading
The biopharmaceutical company priced the offering at $16 a share. The stock debuted at $24, and was recently up 57%, to $25.05. SpyGlass's shares are trading on the Nasdaq Global Select Market under the symbol SGP. The company said it expects to…
AI Could Reshape Clinical Trials-and the Business of Pharma
Welcome back to In the Loop, TIME's new twice-weekly newsletter about AI. If you're reading this in your browser, why not subscribe to have the next one delivered straight to your inbox? We hear a lot about how AI is accelerating drug discovery.
FDA to Restrict Copycat Weight Loss Drugs Sold by Pharma Rivals
The US Food and Drug Administration said it would crack down on copycat weight loss drugs like those marketed by Hims & Hers Health Inc. The telehealth company said Thursday it's selling a deeply discounted version of Novo Nordisk A/S 's new weight…
Karolinska Development's portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement
STOCKHOLM, Sweden, February 6, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has entered into a reverse acquisition agreement with Novakand Pharma. Throughout the agreement, Novakand will…
Fosun Pharma unit licenses lung cancer drug to Eisai in US$1.55 billion deal
A unit of Fosun Pharma has struck a US$1.55 billion deal to license its home-grown cancer drug to Japan's Eisai, adding to a wave of out-licensing agreements that are channelling billions of dollars into Chinese novel drug development. The deal…
Eye Care Firm SpyGlass Pharma Soars 50% After $150 Million IPO
SpyGlass Pharma Inc. shares jumped 50% in the biopharmaceutical firm's trading debut after it raised $150 million in an initial public offering. The company's shares traded at $24 each as of 12:12 p.m. in New York, above its IPO price of $16…
AptarGroup outlines 2026 margin improvement and targets 7%-11% long-term pharma core sales growth amid emergency medicine headwinds (NYSE:ATR)
Earnings Call Insights: AptarGroup (ATR) Q4 2025 CEO Stephan Tanda emphasized 'very strong top line performance' for Q4, with reported sales growing 14% to $963 million and core sales up 5%. Tanda noted, 'Adjusted EBITDA margin was approximately…
GLP-1 draws pharma advertisers to double down on the Super Bowl
This story is part of Digiday's annual coverage of the Super Bowl. More from the series → The Super Bowl offers a massive, if expensive, window of opportunity for advertisers looking to take advantage of its unrivaled audience reach –…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - Here's Why
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report)'s share price gapped down prior to trading on Friday. The stock had previously closed at $68.6950, but opened at $64.0750. Zealand Pharma A/S shares last traded at $64.0750, with a volume of 153…
BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up - Here's What Happened
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $63.73, but opened at $70.07. BridgeBio Pharma shares last traded at $68.4410, with a volume of 782,051 shares…
Thrivent Financial for Lutherans Trims Stake in Royalty Pharma PLC $RPRX
Thrivent Financial for Lutherans lowered its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 13.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 211,305 shares of the…
PDA Introduces the 2026 Board of Directors and Officers
'I congratulate Melissa Seymour for assuming the position of PDA Chair and thank Anil Sawant for his leadership in that position over the last two years,' said Glenn Wright, PDA President and CEO. 'I also want to welcome Ken Paddock and Jackie…
CII meet stresses safety culture in high-risk industries
The CII Andhra Pradesh Conference on Industrial Safety and Environmental Protection in High-Risk Factories held on Friday here aimed to strengthen safety and sustainability across chemical, pharmaceutical and other high-risk industries. The…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0815 GMT – Bayer released data for its asundexian drug candidate for stroke prevention that seem better…
Slate of Biotechs Heads to the Public Markets, Spurring Optimism
Biotechnology companies going public this week are signaling a resurgence for initial public offerings and venture-capital investment in the sector this year. Biotechs Eikon Therapeutics and Veradermics staged initial public offerings this week…
Receive a Daily briefing on Pharma Industry News
Get Started